Alexion to move headquarters out of New Haven

121 Seaport Boston

Its the same as in 2016Q3.

Apple Inc. most recently reported earnings per share (EPS) of $1.67 for the June 2017 versus $1.42 in the same quarter a year ago, representing 18% growth. Breaking that down further, it has performed -0.80% for the week, 8.03% for the month, 33.73% over the last quarter, 14.58% for the past half-year and 14.42% for this a year ago. Prudential Financial Inc. now owns 387,488 shares of the biopharmaceutical company's stock valued at $47,146,000 after buying an additional 77,360 shares in the last quarter. Dubuque National Bank & Trust & Company holds 0% of its portfolio in Alexion Pharmaceuticals, Inc.

Sell-side firms are projecting that the stock will reach 159.75 within the next year. Pennsylvania-based Vantage Advisors Lc has invested 0% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Architects Inc accumulated 32 shares. The institutional investor owned 51,432 shares of the biopharmaceutical company's stock after buying an additional 6,879 shares during the period. Louisiana State Employees Retirement owns 12,300 shares. Camber Capital Management LLC now holds 425,000 shares with a value of $7,170,000. BlackRock Inc. grew its position in shares of Alexion Pharmaceuticals by 2,689.8% during the first quarter. Shares for $1.76 million were sold by MCDOWELL MARY T. 254,583 are owned by Apg Asset Mngmt Nv. Lba Wealth Management Limited Liability Com holds 0% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 9,257 shares. Strs Ohio reported 604,653 shares.

Since June 14, 2017, it had 4 insider buys, and 1 sale for $235.75 million activity. (NASDAQ:ALXN) shares were bought by HANTSON LUDWIG. As of the end of the quarter Janus Capital Management LLC had bought 2,392 shares growing its stake by 17.3%. (NASDAQ:ALXN) was sold by PARVEN ALVIN S on Thursday, June 15. (NASDAQ:ALXN). Moreover, Rockefeller Fin Svcs Incorporated has 0.02% invested in Alexion Pharmaceuticals, Inc. ALXN's total short interest was 4.44 million shares in September as published by FINRA. With 3.82 million shares average volume, it will take short sellers 1 days to cover their ALXN's short positions.

In pre-market trading, Alexion shares were up 1.5% at US$142.93. Ameriprise Financial Inc. now owns 6,149,572 shares of the biopharmaceutical company's stock valued at $745,579,000 after purchasing an additional 454,069 shares in the last quarter. Currently, 226.84 million total shares are owned by the public and among those 222.25 million shares have been available to trade.

The New Haven headquarters was billed as a milestone in New Haven's Downtown Crossing urban revitalization efforts and the city's attempts to expand its life science cluster near Yale School of Medicine. It has underperformed by 34.82% the S&P500. Edge Wealth Mngmt Limited Liability Co invested 0.01% of its portfolio in Alexion Pharmaceuticals, Inc. The company has market cap of $31.62 billion. The Firm is focused on the development and commercialization of therapeutic products. It has a 61.39 P/E ratio. The Company's products include Soliris, Strensiq (asfotase alfa) and Kanuma (sebelipase alfa). $97,511 worth of Alexion Pharmaceuticals, Inc. Therefore 78% are positive. Finally, Oppenheimer Holdings, Inc. upgraded shares of Alexion Pharmaceuticals from a "market perform" rating to an "outperform" rating and set a $175.00 target price on the stock in a research report on Friday, July 28th.

05/23/2017 - Alexion Pharmaceuticals, Inc. had its "buy" rating reiterated by analysts at Stifel Nicolaus. The firm earned "Hold" rating on Tuesday, September 1 by Zacks. Tyrus Sam invested 0.31% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) opened at 141.19 on Monday. The stock has "Underperform" rating by FBR Capital on Thursday, September 15. Brean Capital maintained Alexion Pharmaceuticals, Inc.

Willis Investment Counsel increased United Parcel Service (UPS) stake by 2.13% reported in 2016Q4 SEC filing. Barclays Capital maintained the stock with "Equal-Weight" rating in Friday, July 29 report.

Related News: